NCT00271518View on ClinicalTrials.gov

Treatment of Children With Insufficient Secretion of Growth Hormone

PHASE3UnknownINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

December 31, 2013

Conditions

Growth Hormone Deficiency (GHD)

Interventions

DRUG

growth hormone (somatropin)

dosing regimen is weight based.

Trial Locations (1)

Unknown

Division of Endocrinology, Children's Hospital of Philadelphia, Philadelphia

Sponsors

Lead Sponsor

LG Life Sciences

Collaborators (1)

BioPartners GmbH

All Listed Sponsors

collaborator

BioPartners GmbH

INDUSTRY

lead

LG Life Sciences

INDUSTRY

NCT00271518 - Treatment of Children With Insufficient Secretion of Growth Hormone | Biotech Hunter | Biotech Hunter